TIMP1 and inflammatory myofibroblastic tumor: In addition, we were able to introduce the MMP-9/TIMP-1 mRNA ratio as a putative biomarker to predict the osteogenic capacity of the IM to achieve successful bone repair during the second operative stage, regardless of patient characteristics or IMT failure associated-risk factors.